Eptifibatide Injection IP 20mg/75mg
Eptifibatide Injection IP 20mg/75mg
| Product | Adult dose | Pediatric dose | Adjustment in Renal / Hepatic Impaired patients |
| Unigrilin | 1)Acute Coronary Syndrome ; IV bolus of 180 µg/kg followed by a continuous infusion of 2.0 µg/kg/min until hospital discharge or initiation of CABG surgery, up to 72 hours 2) PCI : IV bolus of 180 µg/kg administered immediately before the initiation of PCI followed by a continuous infusion of 2.0 µg/kg/min & a second 180 µg/kg bolus 10min. after the first bolus | ----------- | Yes |
| Product name | Composition | Indication/s | Strengths | Packing |
| Unigrilin | Eptifibatide | ACS, PCI | 20mg | 1 Vial |
| 75mg | 1 Vial |
| Product name | Storage | Stability after reconstitution | Prep of solution | Diluent |
| Unigrilin (Eptifibatide 20mg / 75mg vials) | Store at 2o-8oC. Vial may be transferred to room temp. storage for a period not to exceed 2 months. Protect from light until administration | ------------ | IV Preparation Bolus injection: withdraw from 10 ml vial (2mg/ml; 10, 100 mL) Continuous infusion: Spike 100 ml vial with vented infusion set (0.75 mg/mL; 100 mL) | ----------- |